The estimated Net Worth of Kevin G Byrnes is at least $670 mil dollars as of 11 November 2021. Mr. Byrnes owns over 12,917 units of Medifast Inc stock worth over $384,756 and over the last 11 years he sold MED stock worth over $149,399. In addition, he makes $136,061 as Independent Director at Medifast Inc.
Kevin has made over 2 trades of the Medifast Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he exercised 12,917 units of MED stock worth $373,560 on 11 November 2021.
The largest trade he's ever made was exercising 12,917 units of Medifast Inc stock on 11 November 2021 worth over $373,560. On average, Kevin trades about 1,133 units every 7 days since 2013. As of 11 November 2021 he still owns at least 21,071 units of Medifast Inc stock.
You can see the complete history of Mr. Byrnes stock trades at the bottom of the page.
Kevin G. Byrnes serves as Independent Director of the Company. since May 23, 2013. Mr. Byrnes has more than 40 years of financial experience working in the retail and commercial banking industries. He was the Chairman of the Board of Bay Bank, with assets of approximately $500 million and 12 branches located in the Baltimore metropolitan area, from 2010 to 2015. Mr. Byrnes served as President/COO and Director of Provident Bank from 2002 to 2009. Provident, acquired by M&T Bank in May 2009, was the largest independent financial institution in the Maryland and Northern Virginia marketplaces at that time, with $6.5 billion in assets, 150 branches and 1,600 employees. Prior to serving at Provident Bank, Mr. Byrnes spent 25 years with the Chase Manhattan Bank in various executive management positions. Mr. Byrnes began his career at Bankers Trust Co. in New York. Mr. Byrnes received a BBA from Pace University.
As the Independent Director of Medifast Inc, the total compensation of Kevin Byrnes at Medifast Inc is $136,061. There are 11 executives at Medifast Inc getting paid more, with Daniel Chard having the highest compensation of $4,669,990.
Kevin Byrnes is 73, he's been the Independent Director of Medifast Inc since 2013. There are no older and 22 younger executives at Medifast Inc.
Kevin's mailing address filed with the SEC is C/O MEDIFAST, INC.,, 100 INTERNATIONAL DRIVE, BALTIMORE, MD, 21202.
Over the last 22 years, insiders at Medifast Inc have traded over $142,340,778 worth of Medifast Inc stock and bought 102,554 units worth $5,201,250 . The most active insiders traders include Glenn W. Welling, Balanced Master Fund, Ltd. ... y Shirley Macdonald. On average, Medifast Inc executives and independent directors trade stock every 42 days with the average trade being worth of $503,538. The most recent stock trade was executed by Scott Schlackman on 8 March 2024, trading 4,053 units of MED stock currently worth $159,850.
since 1980, medifast, inc.(nyse: med) has been a brand recommended by 20,000 doctors. developed by a physician, medifast is a clinically proven nutrition and weight loss company based in maryland. we change lives by producing results and helping those succeed. because everyone has different goals and ways of learning, we offer several support programs as you choose health with medifast. we believe that healthier people are happier people. everyone has the right to feel good about themselves. our vision is to create a world where it's easy to take control of your own well-being. we're on a mission to empower people with the right opportunities to enjoy the healthy life they deserve. we see it every day. the ear-to-ear grin. the “holding back the tears” pride. the glow of pure joy when someone reaches their weight-loss goals. their whole life gets better, and so does yours, because you helped them get there. if you’d like to spend every day helping to change people’s lives for the better
Medifast Inc executives and other stock owners filed with the SEC include: